October 6, 2021 — Understanding the chronic disease of obesity is growing clearer. As this understanding grows, we’re seeing the tie between obesity and type 2 diabetes grow closer. Of course, the overlap of these two diseases is not 100 percent, but it is considerable. Two notable papers this week serve to illustrate. One explains more fully how fat […]
May 8, 2020 — One of the very few blessings of the pandemic lockdown has been a respite from keto mania. Yes, we’ve had to blot out stupid talk about the Quarantine 15. Nonetheless, rants from true believers in ketogenic diets have been on the back burner. Interest in keto everything is down by more than half from where […]
December 27, 2018 — How safe is a drug for type 2 diabetes that causes weight gain? This question pops up as we read a big new study of outcomes with second line drugs for type 2 diabetes. That’s because two types of drugs that cause weight gain – basal insulin and sulfonylureas – had a clear link to bad […]
November 15, 2018 — It’s a recurring frustration. Science is a difficult process of stepwise efforts to uncover the truth. We never get it all at once. And then – especially when the subject is obesity and nutrition – a battle of headlines vs science emerges. Yesterday, this frustration was on vivid display in a packed lecture hall at ObesityWeek. On […]
August 28, 2017 — It’s official as of Friday. Liraglutide (Victoza) is not only for treating type 2 diabetes and obesity. FDA now says it also effectively prevents heart attacks, strokes, and cardiovascular deaths. This new information applies to people taking it for diabetes who also have heart disease. A Dramatic, Ongoing Shift in Diabetes Care This news represents […]
October 31, 2016 — Over the last four years, four new obesity meds gained approval and only one lived up to expectations in the marketplace – the Saxenda brand of liraglutide 3 mg from Novo Nordisk. The company reported quarterly results last week. Saxenda sales, growing impressively, are on track to surpass $200 million for the year. Net profit for […]
February 13, 2015 — Who says scientists can’t be clever marketers. If you doubt it, consider the folks who came up withe the concept of “smart insulin.” This catch phrase conveys so much more than “insulin with aliphatic phenylboronic acid conjugates” ever could. In a time when everybody seems to be carrying a smart phone, why would anybody want dumb […]
